WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Search Results

Filter Results:
  • People (1192)
  • Services (113)
  • Insights (4860)
  • Events (1834)
  • Site Content (65)
Reset Search

People (1192)

Demian Ahn
Partner
Washington, D.C.
Demian Ahn is a member of the firm’s data, privacy, and cybersecurity practice based in Washington, D.C. He leads the firm’s incident response practice and advises companies on compliance, regulatory, and crisis management matters relating to emerging technologies of all kinds.
  • Data, Privacy, and Cybersecurity
View Profile
Josephine Aiello LeBeau
Partner
Washington, D.C.
Josephine focuses on matters related to compliance and enforcement of U.S. export control and sanctions.
  • National Security and Trade
View Profile
Ali R. Alemozafar
Partner
San Francisco
Ali counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
  • Patents and Innovations
View Profile
Lester Ang
Partner
Palo Alto
Lester Ang is a corporate and securities partner in the Palo Alto office of Wilson Sonsini, where he works with private and public technology and life sciences companies through all stages of their growth, as well as with venture capital firms and private equity firms.
  • Corporate
View Profile
Brian Appel
Partner
Palo Alto
Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
  • Corporate
View Profile
Matthew A. Argenti
Partner
Palo Alto
Matt is an experienced patent litigatior with an focus on post-grant review proceedings before the PTAB.
  • Litigation
View Profile
Hin Au
Partner
Palo Alto
Hin Au is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Hin provides IP strategy and counseling services to clients in a wide range of technical fields, including MedTech, digital health, biotech, medical/diagnostic devices, software, robotics, autonomous vehicle technologies, and clean energy. He has assisted many clients with building their patent portfolios and securing key strategic patents. Hin has hands-on engineering industry experience, having previously worked as an R&D engineer for six years at large U.S. semiconductor corporations. A native of Singapore, Hin is also fluent in Mandarin and Cantonese.
  • Patents and Innovations
View Profile
Christine K. Au-Yeung
Partner
San Francisco
Christine Au-Yeung is a partner in the San Francisco and Palo Alto offices of Wilson Sonsini Goodrich & Rosati, where she focuses on trademark, copyright, and advertising law. She counsels clients on all aspects of brand protection in the U.S. and throughout the world, including clearance and selection of trademarks, prosecution of trademark applications, licensing, and the resolution of trademark infringement and domain name disputes. She also advises clients on advertising issues, including TCPA compliance related to marketing calls and texts, as well as strategies on promotions such as sweepstakes and contests.
  • Trademark and Advertising
View Profile
Colleen Bal
Partner
San Francisco
Colleen is a nationally recognized trial lawyer with a proven track record of handling difficult and high-profile cases for leading technology, life sciences, and financial companies.
  • Litigation
View Profile
View All Attorneys

Services (113)

  • Advertising, Promotions, and Marketing
  • AI and Data Center Infrastructure
  • AI in Healthcare
  • Animal Health
  • Anti-Money Laundering
  • Antitrust and Competition
  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance

Insights (4860)

Alerts

7.30.26

Delaware Court of Chancery Issues First Decision Addressing Public Benefit Corporations
On July 29, 2026, Vice Chancellor Nathan Cook of the Delaware Court of Chancery issued a decision addressing, for the first time, the fiduciary duties of directors of a public benefit corporation (PBC)—including in a sale of control.1 Under the PBC form, the purpose of corporate decision-making is not merely to advance stockholder value—as is the ultimate purpose of decision-making for a traditional Delaware corporation—but instead to balance three sets of interests: a specific public benefit purpose chosen by the PBC, the best interests of those materially affected by the corporation’s conduct, and stockholders’ pecuniary interests.2 Delaware law first authorized the PBC form in 2013, and since that time, the form has grown in prominence, with many significant public and private companies operating as PBCs. Until this decision, however, there had not yet been direct case law guidance addressing PBCs. The decision, accordingly, is noteworthy for PBCs and companies considering adopting the PBC form.
Alerts

7.30.26

DOJ Revives Targeted Second Requests for Merger Review
On July 23, 2026, the Department of Justice (DOJ) Antitrust Division announced a return to “targeted” Second Request investigations and published a revised model timing agreement. The agreement offers an optional “Expedited Consideration” process potentially allowing investigations to be resolved without a full Second Request production. Under the expedited procedures, parties produce a limited set of documents, data, and information relevant to particular issues and concerns raised by the Antitrust Division. If the targeted production is sufficient to resolve the DOJ’s concerns, the investigation may be terminated without full Second Request compliance. In addition, the targeted production may provide a context for potential settlement negotiations. If concerns remain, the DOJ may require further productions, either of the full Second Request specifications or on modified terms.
Client Highlights

7.30.26

Firm Advises Lead Investor G2 Venture Partners and Eclipse on Antora Energy’s $500 Million Series C
On July 30, 2026, Antora Energy, a leading U.S. energy storage company, announced its closing on $550 million in Series C funding co-led by G2 Venture Partners and Eclipse, with participation from existing and new investors. Wilson Sonsini Goodrich & Rosati advised G2 Venture Partners and Eclipse on the transaction.
Client Highlights

7.30.26

Firm Advises Secturion Systems on Acquisition by Carlyle Group
On July 27, 2026, global investment firm Carlyle announced that it had acquired Secturion Systems, a leading provider of high-speed, NSA-certified hardware encryption solutions that protect sensitive and classified information. The transaction marks the first investment by Carlyle’s dedicated middle-market Aerospace, Defense & Government, and Industrials platform. Wilson Sonsini Goodrich & Rosati advised Secturion on the transaction.
Client Highlights

7.30.26

Wilson Sonsini Advises Dili on $15 Million Series A Led by Khosla Ventures
On July 30, 2026, Dili, an AI compliance company, announced it has raised $15 million in Series A funding. The round was led by Khosla Ventures, with participation from Allianz, Rebel Fund, Brick and Mortar Ventures' Darren Bechtel, and Y Combinator's Garry Tan. Wilson Sonsini Goodrich & Rosati advised Dili on the transaction.
Alerts

7.29.26

Back-to-Back Executive Orders Shape the U.S. Quantum Agenda: What Founders and Investors Need to Know
On June 22, 2026, the administration issued two Executive Orders: Executive Order 14413, Ushering in the Next Frontier of Quantum Innovation (Quantum Innovation Executive Order) and Executive Order 14412, Securing the Nation Against Advanced Cryptographic Attacks (Post-Quantum Cryptography Executive Order). Together, the Executive Orders reinforce the federal government’s long-term commitment to quantum information science and technology (QIST) while continuing to frame quantum as both an economic and national security priority. Although they impose relatively few immediate legal obligations on most companies, the Executive Orders provide important signals about where federal investment, procurement, and strategic partnerships are likely to emerge over the coming years.
Newsletters

7.29.26

European Antitrust Bimonthly Bulletin – May/June 2026
The firm is pleased to distribute the European Antitrust Bimonthly Bulletin, which distills the major antitrust developments in Europe over the past two months into concise and actionable takeaways. Companies operating in, or transacting with, Europe should take note of this quarter's developments in merger enforcement, digital markets regulation, and AI-related antitrust scrutiny.
News Articles

7.29.26

Weiheng Chen Named Finalist for 2026 ALB Hong Kong Law Awards
Asian Legal Business announced the finalists for its 25th annual ALB Hong Kong Law Awards, which honor outstanding achievements in the legal field, celebrating the exceptional performance of both private practitioners and in-house counsel in Hong Kong. Head of Wilson Sonsini’s Greater China practice Weiheng Chen has been named a finalist in the “Dealmaker of the Year” category. Weiheng has represented clients in many of the largest and most significant M&A and capital markets deals in a variety of industries.
Client Highlights

7.29.26

Wilson Sonsini Advises DroneDeploy on $845 Million Acquisition by Procore Technologies
On July 29, 2026, Procore Technologies, a global provider of construction management software, announced it has entered into a definitive agreement to acquire DroneDeploy, a robotics and visual intelligence platform. Procore will acquire DroneDeploy for approximately $845 million in cash, subject to customary purchase price adjustments. Wilson Sonsini Goodrich & Rosati is advising DroneDeploy on the transaction
View All Insights

Events (1834)

Affiliated Programs

12.03.26

Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
This full-day workshop will be taught by accomplished business development (BD) professionals with deep experience in both large pharmas and small biotechs, providing perspectives from both sides of the table for biopartnering. If you have ever wondered what BD is, how to work efficiently and effectively with your BD team to advance your company’s strategy and programs, or even how to become a BD professional yourself, this is a good workshop for you (and your colleagues in R&D, regulatory, legal, finance, and even executive positions) to attend. The workshop will include presentations, case studies, and group exercises, and conclude with a panel discussion. 
Affiliated Programs

10.21.26

Intellectual Property (IP) for Antibody and Related Therapeutics: Strategies, Best Practices and Case Studies
Antibody and related biologic therapeutics present unique intellectual property (IP) challenges throughout discovery, development, and commercialization. This online workshop will bring together IP attorneys and industry experts from Haynes Boone, Wilson Sonsini, Morgan Lewis, Morrison Foerster, and Amgen to discuss practical strategies, emerging legal issues, and real-world case studies. Attendees will gain insights into protecting innovation, managing IP risks, and navigating an evolving legal landscape shaped by advances in biologics and AI.
Affiliated Programs

10.20.26

East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs

10.16.26

Discovery and Development of Orally Bioavailable Peptides from Concept to Clinic: Structural Design, Formulation Development, Translational Science, and IP Issues
Wilson Sonsini is proud to sponsor the Pharmaceutical & BioScience Society (PBSS).
Affiliated Programs

9.15.26

West Coast NextGen VC Forum
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
WSGR Events

9.09.26

The EU Data Act - One Year On Webinar
On September 12, 2025, the EU Data Act introduced new obligations for companies that manufacture connected products, provide related services, offer cloud or SaaS services in the EU, or participate in EU data-sharing arrangements.
Speaking Engagements

8.12.26

AI and Data Privacy
On August 12, Wilson Sonsini partner Maneesha Mithal will participate in the webinar "AI and Data Privacy" alongside Tina Shah Paikeday, General Manager and Responsible AI Senior Advisor at Findem. They will examine individual considerations for managing personal information in an AI-enabled hiring landscape and will discuss key organizational considerations for protecting data and navigating evolving global privacy regulations. To register for the free webinar, please visit the event website.
Affiliated Programs

8.11.26

California Powers Up: Energy & Policy Solutions Summit
Wilson Sonsini are excited to sponsor Advanced Energy United's CA Powers Up: Energy & Policy Solution Summit on August 11th. Join us at the summit where partner Todd Glass will moderate the panel "Navigating the Road Ahead: What's in Store for the Next Governor." The event will provide real answers to California’s most pressing energy questions through thought-provoking panels and breakout sessions. Attendees will have the opportunity to network with policymakers and regulators influencing state energy decisions, as well as executives of companies deploying clean energy solutions. 
Affiliated Programs

8.05.26

7th In-House Impact: Biopharma Summit
Wilson Sonsini is pleased to sponsor the 7th In-House Impact: Biopharma Summit, a premier gathering designed exclusively for general counsels, chief legal officers, and senior in-house legal leaders across the biopharma industry.
View All Events

Site Content (65)

  • About Us
  • Alternative Legal Careers
  • Apply Online
  • Associates Committee
  • Austin
  • Benefits Snapshot
  • Board of Directors
  • Boston
  • Boulder
  • Brussels
  • Business Professionals
  • Career Management Center
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.